• Dr. Joseph Barney is Associate Professor of Medicine at the University of Alabama at Birmingham. With the exception of his time at Mercer University School of Medicine, Dr. Barney's entire medical career has been centered around UAB, from his internship in 2000 to his current practice. Dr. Barney has served as critical care transport physician, a volunteer staff physicians in local clinics, and has contributed greatly to the study and treatment of sarcoidosis.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2022 The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registryRespiratory Medicine.  196. 2022
    2021 Reply to: Intraosseous Versus Intravenous Resuscitation During In-Hospital Cardiac ArrestResuscitation.  169:203-204. 2021
    2021 Impact of intraosseous versus intravenous resuscitation during in-hospital cardiac arrest: A retrospective studyResuscitation.  166:7-13. 2021
    2021 Pulmonary actinomycosis and marijuana vapingBMJ Case Reports.  14. 2021
    2021 A National Survey of Burnout and Depression Among Fellows Training in Pulmonary and Critical Care Medicine: A Special Report by the Association of Pulmonary and Critical Care Medicine Program DirectorsChest.  159:733-742. 2021
    2020 Physiological predictors of survival in patients with sarcoidosis associated pulmonary hypertension: Results from an international registryEuropean Respiratory Journal.  55. 2020
    2020 Capsule Commentary on Griffith et al., Overuse and Misuse of Inhaled Corticosteroids Among Veterans with COPD: a Cross-Sectional Study Evaluating Targets for De-implementationJournal of General Internal Medicine.  35:979. 2020
    2020 Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosisEuropean Respiratory Review.  29. 2020
    2020 Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: A delphi studyEuropean Respiratory Review.  29. 2020
    2018 Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registryRespiratory Medicine.  139:72-78. 2018
    2016 A retrospective pilot study examining the use of Acthar gel in sarcoidosis patientsRespiratory Medicine.  110:66-72. 2016
    2015 A qualitative investigation of patients' and caregivers' experiences of severe sepsisCritical Care Medicine.  43:296-307. 2015
    2014 Characteristics of patients with pulmonary venoocclusive disease awaiting transplantationAnnals of the American Thoracic Society.  11:1411-1418. 2014
    2014 A qualitative assessment of internal medicine resident perceptions of graduate medical education following implementation of the 2011 ACGME duty hour standardsBMC Medical Education.  14. 2014
    2014 Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosisEuropean Respiratory Journal.  44:1296-1307. 2014
    2008 Bronchiolitis obliterans syndrome and survival following lung transplantation for patients with sarcoidosisSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders.  25:117-124. 2008
    2006 An unusual cause of chronic cough: Foreign body aspirationJournal of General Internal Medicine.  21. 2006

    Research Overview

  • Dr. Barney's research interests include pulmonary fibrosis, interstitial lung disease, and sarcoidosis.
  • Principal Investigator On

  • Private Grant  awarded by EISAI MEDICAL RESEARCH, INC.
  • Private Grant  awarded by NCGS LABORATORIES, INC.
  • Private Grant  awarded by ELI LILLY AND COMPANY
  • Private Grant  awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC
  • Private Grant  awarded by OXFORD OUTCOMES, INC
  • Private Grant  awarded by FURIEX PHARMACEUTICALS, INC.
  • Private Grant  awarded by SPECTRAL MEDICAL, INC.
  • Private Grant  awarded by GlaxoSmithKline
  • Private Grant  awarded by AGENNIX, INC.
  • Private Grant  awarded by CELGENE CORPORATION
  • Private Grant  awarded by Sanofi US Services Inc
  • Private Grant  awarded by PORTOLA PHARMACEUTICALS, INC.
  • Private Grant  awarded by ASAHI KASEI PHARMA AMERICA
  • Private Grant  awarded by Pfizer Pharmaceuticals
  • Private Grant  awarded by Bayer Inc.
  • Private Grant  awarded by LA JOLLA PHARMACEUTICAL COMPANY
  • Private Grant  awarded by Ferring Pharmaceuticals
  • Private Grant  awarded by CELGENE CORPORATION
  • Private Grant  awarded by MALLINCKRODT ARD, INC
  • Private Grant  awarded by ATYR PHARMA, INC.
  • Private Grant  awarded by KINEVANT SCIENCES INC
  • Private Grant  awarded by KINEVANT SCIENCES INC
  • Private Grant  awarded by ATYR PHARMA, INC.
  • Registry of Sarcoidosis Associated Pulmonary Hypertension (ReSAPH)  awarded by UNIVERSITY OF CINCINNATI PHYSICIANS COMPANY
  • Trial of Aromatase Inhibition in Lyphangioleiomyomatosis  awarded by University of Cincinnati
  • Education And Training

  • University of Alabama at Birmingham, Internship
  • University of Alabama at Birmingham, Residency
  • Doctor of Medicine, Mercer University 2000
  • Full Name

  • Joseph Barney